CALATRONI, MARTA
 Distribuzione geografica
Continente #
AS - Asia 1.274
NA - Nord America 1.066
EU - Europa 340
SA - Sud America 166
AF - Africa 29
OC - Oceania 3
Totale 2.878
Nazione #
US - Stati Uniti d'America 1.029
SG - Singapore 729
CN - Cina 277
BR - Brasile 135
VN - Vietnam 122
IT - Italia 114
HK - Hong Kong 45
DE - Germania 31
FI - Finlandia 31
IE - Irlanda 29
GB - Regno Unito 27
IN - India 24
MK - Macedonia 20
MX - Messico 16
FR - Francia 14
PL - Polonia 14
AR - Argentina 13
BD - Bangladesh 13
NL - Olanda 13
CA - Canada 12
PH - Filippine 9
RU - Federazione Russa 8
UA - Ucraina 8
ES - Italia 7
IQ - Iraq 7
PK - Pakistan 6
SE - Svezia 5
TN - Tunisia 5
TR - Turchia 5
AE - Emirati Arabi Uniti 4
AT - Austria 4
CL - Cile 4
CO - Colombia 4
EC - Ecuador 4
EG - Egitto 4
JP - Giappone 4
MA - Marocco 4
NG - Nigeria 4
TW - Taiwan 4
VE - Venezuela 4
AU - Australia 3
AZ - Azerbaigian 3
DZ - Algeria 3
LV - Lettonia 3
NI - Nicaragua 3
PA - Panama 3
ZA - Sudafrica 3
BB - Barbados 2
CH - Svizzera 2
ET - Etiopia 2
ID - Indonesia 2
IL - Israele 2
KE - Kenya 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
PE - Perù 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
EE - Estonia 1
GR - Grecia 1
HR - Croazia 1
JO - Giordania 1
KH - Cambogia 1
KR - Corea 1
LT - Lituania 1
MT - Malta 1
MY - Malesia 1
MZ - Mozambico 1
OM - Oman 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
UG - Uganda 1
Totale 2.878
Città #
Singapore 363
Ashburn 197
San Jose 155
Shanghai 110
The Dalles 98
Beijing 81
Boardman 65
Dallas 64
New York 58
Hong Kong 44
Ho Chi Minh City 37
Hanoi 34
Helsinki 31
Milan 31
Dublin 29
Naples 26
Chandler 19
Los Angeles 14
Phoenix 14
Brooklyn 10
Haiphong 10
Seattle 10
Warsaw 10
Wilmington 10
Santa Clara 9
Skopje 9
Assago 8
Mexico City 8
Orem 8
São Paulo 8
Washington 8
Frankfurt am Main 7
London 7
Paris 7
Chennai 6
Council Bluffs 6
Rio de Janeiro 6
Bitola 5
Montreal 5
Amsterdam 4
Benin City 4
Buenos Aires 4
Da Nang 4
Neipu 4
Santiago 4
Stockholm 4
Tokyo 4
Baku 3
Belo Horizonte 3
Boston 3
Buffalo 3
Denver 3
Fort Worth 3
Hillsboro 3
Houston 3
Karachi 3
Managua 3
Mumbai 3
Munich 3
Olongapo City 3
Panama City 3
Poplar 3
Portland 3
Prilep 3
Prineville 3
Riga 3
San Mateo 3
Springfield 3
Uberlândia 3
Addis Ababa 2
Algiers 2
Ankara 2
Baghdad 2
Bari 2
Belém 2
Bishkek 2
Bogovinje 2
Cairo 2
Campos dos Goytacazes 2
Caxias do Sul 2
Chandigarh 2
Concórdia 2
Delhi 2
Dhaka 2
Dubai 2
Falkenstein 2
Farmington Hills 2
Florence 2
Franca 2
Gdansk 2
Guarulhos 2
Hải Dương 2
Johannesburg 2
Kyiv 2
Las Pinas 2
Lawrence 2
Lima 2
Macaé 2
Manchester 2
Miami 2
Totale 1.787
Nome #
Outcome of Sars-COV-2-related thyrotoxicosis in survivors of Covid-19: a prospective study 203
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 128
Impact of chronic exposure to 5-alpha reductase inhibitors on the risk of hospitalization for COVID-19: a case-control study in male population from two COVID-19 regional centers of Lombardy, Italy 76
Goodpasture syndrome and anti-glomerular basement membrane disease 70
Kidney Biopsy in Pregnant Women with Glomerular Diseases: Focus on Lupus Nephritis 68
[Heparin-induced trombocytopenia: pathogenesis, clinical manifestations and management in hemodialysis] 66
Herpes zoster in lupus nephritis: experience on 292 patients followed up for 15 years 65
Beyond ISN/RPS Lupus Nephritis Classification: Adding Chronicity Index to Clinical Variables Predicts Kidney Survival 64
Long-term kidney outcome of patients with rheumatological diseases and antineutrophil cytoplasmic antibody-glomerulonephritis: comparison with a primitive ANCA-glomerulonephritis cohort 63
Clinical and histological findings at second but not at first kidney biopsy predict end-stage kidney disease in a large multicentric cohort of patients with active lupus nephritis 63
ANCA-associated vasculitis in childhood: Recent advances 62
Comparative Analysis of Antithrombotic Therapy Outcomes in Mild Traumatic Brain-Injury Patients: A Focus on Bleeding Risk and Hospital-Stay Duration 61
Comparison of EULAR/PRINTO/PReS Ankara 2008 and 2022 ACR/EULAR Classification Criteria for Granulomatosis with Polyangiitis in Children 59
Changing Phenotypes and Clinical Outcomes Over Time in Microscopic Polyangiitis 59
Effect of Sustained Clinical Remission on the Risk of Lupus Flares and Impaired Kidney Function in Patients With Lupus Nephritis 58
Global Performance Status Score: A New Tool to Assess Physical Performance in Kidney Transplant Patients 57
Blood Thiol Redox State in Chronic Kidney Disease 57
Understanding fluid dynamics and renal perfusion in acute kidney injury management 57
Severe cyclophosphamide-related hyponatremia in a patient with acute glomerulonephritis 56
Monoclonal gammopathy in lupus nephritis 53
Anti-neutrophil cytoplasmic antibody-associated vasculitis in kidney transplantation 53
Adverse events linked with the use of chimeric and humanized anti-CD20 antibodies in children with idiopathic nephrotic syndrome 53
{"}Deep{"} purple urine bag syndrome: physiopathology and clinical implications,La Sindrome delle urine viola: patogenesi e significato clinico 52
Anti-C1q antibodies: a biomarker for diagnosis and management of lupus nephritis. A narrative review 52
The Role of Rituximab in Primary Focal Segmental Glomerular Sclerosis of the Adult 51
Is per-protocol kidney biopsy required in lupus nephritis? 50
Prevalence and clinical significance of ANCA positivity in lupus nephritis: a case series of 116 patients and literature review 50
The value of the current histological scores and classifications of ANCA glomerulonephritis in predicting long-term outcome 50
Prognostic factors and long-term outcome with anca-associated kidney vasculitis in childhood 50
Kinetics of the Cell Cycle Arrest Biomarkers (TIMP2 and IGFBP7) for the Diagnosis of Acute Kidney Injury in Critically Ill COVID-19 Patients 49
Anti-C1Q monitoring predicts relapses of lupus nephritis 49
Predictors of increase in chronicity index and of kidney function impairment at repeat biopsy in lupus nephritis 48
Slowly progressive anti-neutrophil cytoplasmic antibody-associated renal vasculitis: Clinico-pathological characterization and outcome 48
Spontaneous rupture of a simple renal cyst: clinical management [Rottura spontanea di cisti renale semplice: gestione clinica] 48
Modulation of Myostatin/Hepatocyte Growth Factor Balance by Different Hemodialysis Modalities 48
Anti-glomerular basement membrane vasculitis 48
C3 glomerulopathies: dense deposit disease and C3 glomerulonephritis 47
Immunohistochemical Evaluation of Renal Biopsy with Anti-PD1 and p53 to Solve the Dilemma between Platinum- and Pembrolizumab-Induced AKI: Case Report and Review 46
Renal involvement in mushroom poisoning: The case of Orellanus syndrome 44
Microplastics and Kidneys: An Update on the Evidence for Deposition of Plastic Microparticles in Human Organs, Tissues and Fluids and Renal Toxicity Concern 44
Renal replacement therapy in sarcoidosis 43
Enhancing clinical nutrition education for healthcare professionals: Engagement through active learning methodologies 41
Using Renal Elastography to Predict the Therapeutic Response of Nephrological Patients 39
Ursodeoxycholic Acid Does Not Improve COVID-19 Outcome in Hospitalized Patients 39
The evolving paradigm of cancer risk related to cyclophosphamide therapy in granulomatosis with polyangiitis 38
Impact of Mayo Adhesive Probability score and BMI on renal functional decline after robotic assisted partial nephrectomy 37
Treatment strategies for ANCA-associated vasculitides: from standard protocols to future horizons 36
Renal involvement in eosinophilic granulomatosis with polyangiitis 36
The Impact of Preeclampsia in Lupus Nephritis 35
Volume balance in chronic kidney disease: Evaluation methodologies and innovation opportunities 35
Hospital Malnutrition in the Medicine and Neurology Departments: A Complex Challenge 34
Renal sarcoidosis 32
Integrated protocol for the prevention and treatment of skin ulcers in patients with end-stage renal disease 32
Severe lupus nephritis in the present days 29
Clinical presentation, outcomes and risk of relapses of lupus podocytopathy in a multicentre Italian cohort 22
Clinical and immunological biomarkers can identify proliferative changes and predict renal flares in lupus nephritis 13
Totale 2.966
Categoria #
all - tutte 15.627
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.627


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202114 0 0 0 0 0 0 0 0 0 1 0 13
2021/202219 0 1 1 2 0 0 1 2 0 2 9 1
2022/2023104 5 2 4 3 7 7 4 6 20 5 7 34
2023/2024496 58 22 76 46 18 63 57 35 17 6 42 56
2024/2025738 10 41 14 20 20 59 29 88 106 154 101 96
2025/20261.576 253 112 67 124 108 117 481 114 91 109 0 0
Totale 2.966